|
|
|
1
|
Choi EH, Ehrmantraut M, Foster CB, Moss J, Chanock SJ.
Association of Common Haplotypes of Surfactant Protein A1 and A2 (SFTPA1 and SFTPA2) Genes with Severity of Lung Disease in Cystic Fibrosis.
Pediatr Pulmonol 41(3): 255-62, 2006.
[Text Abstract on PubMed]
|
|
|
2
|
Citterio C, Jones HD, Pacheco-Rodriguez G, Islam A, Moss J, Vaughan M.
Effect of protein kinase A on accumulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) in HepG2 cell nuclei.
Proc Natl Acad Sci U S A: 2006.
[Text Abstract on PubMed]
|
|
|
3
|
Oka S, Kato J, Moss J.
Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase.
J Biol Chem 281(2): 705-13, 2006.
[Text Abstract on PubMed]
|
|
|
4
|
Aoki K, Kato J, Shoemaker MT, Moss J.
Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
Gene 351: 83-95, 2005.
[Text Abstract on PubMed]
|
|
|
5
|
Avila NA, Dwyer AJ, Murphy-Johnson DV, Brooks P, Moss J.
Sonography of lymphangioleiomyoma in lymphangioleiomyomatosis: demonstration of diurnal variation in lesion size.
AJR Am J Roentgenol 184(2): 459-64, 2005.
[Text Abstract on PubMed]
|
|
|
6
|
Jones HD, Moss J, Vaughan M.
BIG1 and BIG2, brefeldin A-inhibited guanine nucleotide-exchange factors for ADP-ribosylation factors.
Methods Enzymol 404: 174-84, 2005.
[Text Abstract on PubMed]
|
|
|
7
|
Kristof AS, Pacheco-Rodriguez G, Schremmer B, Moss J.
LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms.
J Pharmacol Exp Ther 314(3): 1134-43, 2005.
[Text Abstract on PubMed]
|
|
|
8
|
Li S, Takeuchi F, Wang JA, Fuller C, Pacheco-Rodriguez G, Moss J, Darling TN.
MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development.
J Exp Med 202(5): 617-24, 2005.
[Text Abstract on PubMed]
|
|
|
9
|
Pacheco-Rodriguez G, Moss J, Vaughan M.
Cytohesin-1: structure, function, and ARF activation.
Methods Enzymol 404: 184-95, 2005.
[Text Abstract on PubMed]
|
|
|
10
|
Steagall WK, Taveira-DaSilva AM, Moss J.
Clinical and molecular insights into lymphangioleiomyomatosis.
Sarcoidosis Vasc Diffuse Lung Dis 22 Suppl 1: S49-66, 2005.
[Text Abstract on PubMed]
|
|
|
11
|
Taveira-Dasilva AM, Stylianou MP, Hedin CJ, Hathaway O, Moss J.
Bone mineral density in lymphangioleiomyomatosis.
Am J Respir Crit Care Med 171(1): 61-7, 2005.
[Text Abstract on PubMed]
|
|
|
12
|
Tesauro M, Thompson WC, Moss J.
Effect of staurosporine-induced apoptosis on endothelial nitric oxide synthase in transfected COS-7 cells and primary endothelial cells.
Cell Death Differ: 2005.
[Text Abstract on PubMed]
|
|
|
13
|
Vichi A, Moss J, Vaughan M.
ADP-ribosylation factor domain protein 1 (ARD1), a multifunctional protein with ubiquitin E3 ligase, GAP, and ARF domains.
Methods Enzymol 404: 195-206, 2005.
[Text Abstract on PubMed]
|
|
|
14
|
Vichi A, Payne DM, Pacheco-Rodriguez G, Moss J, Vaughan M.
E3 ubiquitin ligase activity of the trifunctional ARD1 (ADP-ribosylation factor domain protein 1).
Proc Natl Acad Sci U S A 102(6): 1945-50, 2005.
[Text Abstract on PubMed]
|
|
|
15
|
Xu KF, Shen X, Li H, Pacheco-Rodriguez G, Moss J, Vaughan M.
Interaction of BIG2, a brefeldin A-inhibited guanine nucleotide-exchange protein, with exocyst protein Exo70.
Proc Natl Acad Sci U S A 102(8): 2784-9, 2005.
[Text Abstract on PubMed]
|
|
|
16
|
Cowen EW, Rabel A, Nava V, Turner M, Moss J.
Eruptive linear papules on the abdomen of a woman with ascites.
J Am Acad Dermatol 51(1): 75-8, 2004.
[Text Abstract on PubMed]
|
|
|
17
|
Crooks DM, Pacheco-Rodriguez G, DeCastro RM, McCoy JP, Wang JA, Kumaki F, Darling T, Moss J.
Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis.
Proc Natl Acad Sci U S A 101(50): 17462-7, 2004.
[Text Abstract on PubMed]
|
|
|
18
|
Padilla PI, Pacheco-Rodriguez G, Moss J, Vaughan M.
Nuclear localization and molecular partners of BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.
Proc Natl Acad Sci U S A 101(9): 2752-7, 2004.
[Text Abstract on PubMed]
|
|
|
19
|
Taveira-DaSilva AM, Stylianou MP, Hedin CJ, Hathaway O, Moss J.
Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone.
Chest 126(6): 1867-74, 2004.
[Text Abstract on PubMed]
|
|
|
20
|
Bourgeois C, Okazaki I, Cavanaugh E, Nightingale M, Moss J.
Identification of regulatory domains in ADP-ribosyltransferase-1 that determine transferase and NAD glycohydrolase activities.
J Biol Chem 278(29): 26351-5, 2003.
[Text Abstract on PubMed]
|
|
|
21
|
Kristof AS, Marks-Konczalik J, Billings E, Moss J.
Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-gamma is regulated by mammalian target of rapamycin.
J Biol Chem 278(36): 33637-44, 2003.
[Text Abstract on PubMed]
|
|
|
22
|
Li H, Adamik R, Pacheco-Rodriguez G, Moss J, Vaughan M.
Protein kinase A-anchoring (AKAP) domains in brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2).
Proc Natl Acad Sci U S A 100(4): 1627-32, 2003.
[Text Abstract on PubMed]
|
|
|
23
|
Padilla PI, Chang MJ, Pacheco-Rodriguez G, Adamik R, Moss J, Vaughan M.
Interaction of FK506-binding protein 13 with brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1): effects of FK506.
Proc Natl Acad Sci U S A 100(5): 2322-7, 2003.
[Text Abstract on PubMed]
|
|
|
24
|
Stevens LA, Bourgeois C, Bortell R, Moss J.
Regulatory role of arginine 204 in the catalytic activity of rat alloantigens ART2a and ART2b.
J Biol Chem 278(22): 19591-6, 2003.
[Text Abstract on PubMed]
|
|
|
25
|
Taveira-DaSilva AM, Stylianou MP, Hedin CJ, Kristof AS, Avila NA, Rabel A, Travis WD, Moss J.
Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis.
Am J Respir Crit Care Med 168(12): 1427-31, 2003.
[Text Abstract on PubMed]
|
|
|
26
|
Avila NA, Kelly JA, Dwyer AJ, Johnson DL, Jones EC, Moss J.
Lymphangioleiomyomatosis: correlation of qualitative and quantitative thin-section CT with pulmonary function tests and assessment of dependence on pleurodesis.
Radiology 223(1): 189-97, 2002.
[Text Abstract on PubMed]
|
|
|
27
|
Kumaki F, Takeda K, Yu ZX, Moss J, Ferrans VJ.
Expression of human telomerase reverse transcriptase in lymphangioleiomyomatosis.
Am J Respir Crit Care Med 166(2): 187-91, 2002.
[Text Abstract on PubMed]
|
|
|
28
|
Moss J, Vaughan M.
Cytohesin-1 in 2001.
Arch Biochem Biophys 397(2): 156-61, 2002.
[Text Abstract on PubMed]
|
|
|
29
|
Pacheco-Rodriguez G, Kristof AS, Stevens LA, Zhang Y, Crooks D, Moss J.
Giles F. Filley Lecture. Genetics and gene expression in lymphangioleiomyomatosis.
Chest 121(3 Suppl): 56S-60S, 2002.
[Text Abstract on PubMed]
|
|
|
30
|
Pacheco-Rodriguez G, Moss J, Vaughan M.
ARF-directed guanine-nucleotide-exchange (GEP) proteins.
Methods Mol Biol 189: 181-9, 2002.
[Text Abstract on PubMed]
|
|
|
31
|
Pacheco-Rodriguez G, Moss J, Vaughan M.
BIG1 and BIG2: brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors.
Methods Enzymol 345: 397-404, 2002.
[Text Abstract on PubMed]
|
|
|
32
|
Paone G, Wada A, Stevens LA, Matin A, Hirayama T, Levine RL, Moss J.
ADP ribosylation of human neutrophil peptide-1 regulates its biological properties.
Proc Natl Acad Sci U S A 99(12): 8231-5, 2002.
[Text Abstract on PubMed]
|
|
|
33
|
Avila NA, Bechtle J, Dwyer AJ, Ferrans VJ, Moss J.
Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas.
Radiology 221(2): 415-21, 2001.
[Text Abstract on PubMed]
|
|
|
34
|
Kelly J, Moss J.
Lymphangioleiomyomatosis.
Am J Med Sci 321(1): 17-25, 2001.
[Text Abstract on PubMed]
|
|
|
35
|
Kristof AS, Marks-Konczalik J, Moss J.
Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation.
J Biol Chem 276(11): 8445-52, 2001.
[Text Abstract on PubMed]
|
|
|
36
|
Matsui K, Beasley MB, Nelson WK, Barnes PM, Bechtle J, Falk R, Ferrans VJ, Moss J, Travis WD.
Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score.
Am J Surg Pathol 25(4): 479-84, 2001.
[Text Abstract on PubMed]
|
|
|
37
|
Matsui K, Travis WD, Gonzalez R, Terzian JA, Rosai J, Moss J, Ferrans VJ.
Association of lymphangioleiomyomatosis (LAM) with endosalpingiosis in the retroperitoneal lymph nodes: report of two cases.
Int J Surg Pathol 9(2): 155-62, 2001.
[Text Abstract on PubMed]
|
|
|
38
|
Moss J, Avila NA, Barnes PM, Litzenberger RA, Bechtle J, Brooks PG, Hedin CJ, Hunsberger S, Kristof AS.
Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex.
Am J Respir Crit Care Med 164(4): 669-71, 2001.
[Text Abstract on PubMed]
|
|
|
39
|
Moss J, DeCastro R, Patronas NJ, Taveira-DaSilva A.
Meningiomas in lymphangioleiomyomatosis.
JAMA 286(15): 1879-81, 2001.
[Text Abstract on PubMed]
|
|
|
40
|
Moss J, Ehrmantraut ME, Banwart BD, Frank DW, Barbieri JT.
Sera from adult patients with cystic fibrosis contain antibodies to Pseudomonas aeruginosa type III apparatus.
Infect Immun 69(2): 1185-8, 2001.
[Text Abstract on PubMed]
|
|
|
41
|
Moss J.
Introduction to symposium: clinical and molecular insights from uncommon lung diseases.
Am J Med Sci 321(1): 1-2, 2001.
[Text Abstract on PubMed]
|
|
|
42
|
Pacheco-Rodriguez G, Moss J, Vaughan M.
Isolation, cloning, and characterization of brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factor.
Methods Enzymol 329: 300-6, 2001.
[Text Abstract on PubMed]
|
|
|
43
|
Pacheco-Rodriguez G, Moss J, Vaughan M.
Preparation and assay of recombinant ADP-ribosylation factor-like protein-1 (ARL1).
Methods Enzymol 329: 424-8, 2001.
[Text Abstract on PubMed]
|
|
|
44
|
Someya A, Sata M, Takeda K, Pacheco-Rodriguez G, Ferrans VJ, Moss J, Vaughan M.
ARF-GEP(100), a guanine nucleotide-exchange protein for ADP-ribosylation factor 6.
Proc Natl Acad Sci U S A 98(5): 2413-8, 2001.
[Text Abstract on PubMed]
|
|
|
45
|
Taveira-DaSilva AM, Hedin C, Stylianou MP, Travis WD, Matsui K, Ferrans VJ, Moss J.
Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis.
Am J Respir Crit Care Med 164(6): 1072-6, 2001.
[Text Abstract on PubMed]
|
|
|
46
|
Valencia JC, Matsui K, Bondy C, Zhou J, Rasmussen A, Cullen K, Yu ZX, Moss J, Ferrans VJ.
Distribution and mRNA expression of insulin-like growth factor system in pulmonary lymphangioleiomyomatosis.
J Investig Med 49(5): 421-33, 2001.
[Text Abstract on PubMed]
|
|
|
47
|
Avila NA, Chen CC, Chu SC, Wu M, Jones EC, Neumann RD, Moss J.
Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests.
Radiology 214(2): 441-6, 2000.
[Text Abstract on PubMed]
|
|
|
48
|
Avila NA, Kelly JA, Chu SC, Dwyer AJ, Moss J.
Lymphangioleiomyomatosis: abdominopelvic CT and US findings.
Radiology 216(1): 147-53, 2000.
[Text Abstract on PubMed]
|
|
|
49
|
Matsui K, K Riemenschneider W, Hilbert SL, Yu ZX, Takeda K, Travis WD, Moss J, Ferrans VJ.
Hyperplasia of type II pneumocytes in pulmonary lymphangioleiomyomatosis.
Arch Pathol Lab Med 124(11): 1642-8, 2000.
[Text Abstract on PubMed]
|
|
|
50
|
Matsui K, Takeda K, Yu ZX, Travis WD, Moss J, Ferrans VJ.
Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis.
Arch Pathol Lab Med 124(2): 267-75, 2000.
[Text Abstract on PubMed]
|
|
|
51
|
Matsui K, Takeda K, Yu ZX, Valencia J, Travis WD, Moss J, Ferrans VJ.
Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study.
Am J Respir Crit Care Med 161(3 Pt 1): 1002-9, 2000.
[Text Abstract on PubMed]
|
|
|
52
|
Matsui K, Tatsuguchi A, Valencia J, Yu Z, Bechtle J, Beasley MB, Avila N, Travis WD, Moss J, Ferrans VJ.
Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases.
Hum Pathol 31(10): 1242-8, 2000.
[Text Abstract on PubMed]
|
|
|
53
|
Ogasawara M, Kim SC, Adamik R, Togawa A, Ferrans VJ, Takeda K, Kirby M, Moss J, Vaughan M.
Similarities in function and gene structure of cytohesin-4 and cytohesin-1, guanine nucleotide-exchange proteins for ADP-ribosylation factors.
J Biol Chem 275(5): 3221-30, 2000.
[Text Abstract on PubMed]
|
|
|
54
|
Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J.
Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298.
Proc Natl Acad Sci U S A 97(6): 2832-5, 2000.
[Text Abstract on PubMed]
|
|
|
55
|
Vitale N, Ferrans VJ, Moss J, Vaughan M.
Identification of lysosomal and Golgi localization signals in GAP and ARF domains of ARF domain protein 1.
Mol Cell Biol 20(19): 7342-52, 2000.
[Text Abstract on PubMed]
|
|
|
56
|
Vitale N, Pacheco-Rodriguez G, Ferrans VJ, Riemenschneider W, Moss J, Vaughan M.
Specific functional interaction of human cytohesin-1 and ADP-ribosylation factor domain protein (ARD1).
J Biol Chem 275(28): 21331-9, 2000.
[Text Abstract on PubMed]
|
|
|
57
|
Yamaji R, Adamik R, Takeda K, Togawa A, Pacheco-Rodriguez G, Ferrans VJ, Moss J, Vaughan M.
Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex.
Proc Natl Acad Sci U S A 97(6): 2567-72, 2000.
[Text Abstract on PubMed]
|
|
|
58
|
Balducci E, Horiba K, Usuki J, Park M, Ferrans VJ, Moss J.
Selective expression of RT6 superfamily in human bronchial epithelial cells.
Am J Respir Cell Mol Biol 21(3): 337-46, 1999.
[Text Abstract on PubMed]
|
|
|
59
|
Chu SC, Horiba K, Usuki J, Avila NA, Chen CC, Travis WD, Ferrans VJ, Moss J.
Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis.
Chest 115(4): 1041-52, 1999.
[Text Abstract on PubMed]
|
|
|
60
|
Konczalik P, Moss J.
Identification of critical, conserved vicinal aspartate residues in mammalian and bacterial ADP-ribosylarginine hydrolases.
J Biol Chem 274(24): 16736-40, 1999.
[Text Abstract on PubMed]
|
|
|
61
|
Matsumoto Y, Horiba K, Usuki J, Chu SC, Ferrans VJ, Moss J.
Markers of cell proliferation and expression of melanosomal antigen in lymphangioleiomyomatosis.
Am J Respir Cell Mol Biol 21(3): 327-36, 1999.
[Text Abstract on PubMed]
|
|
|
62
|
Meacci E, Vasta V, Moorman JP, Bobak DA, Bruni P, Moss J, Vaughan M.
Effect of Rho and ADP-ribosylation factor GTPases on phospholipase D activity in intact human adenocarcinoma A549 cells.
J Biol Chem 274(26): 18605-12, 1999.
[Text Abstract on PubMed]
|
|
|
63
|
Morinaga N, Adamik R, Moss J, Vaughan M.
Brefeldin A inhibited activity of the sec7 domain of p200, a mammalian guanine nucleotide-exchange protein for ADP-ribosylation factors.
J Biol Chem 274(25): 17417-23, 1999.
[Text Abstract on PubMed]
|
|
|
64
|
Moss J, Balducci E, Cavanaugh E, Kim HJ, Konczalik P, Lesma EA, Okazaki IJ, Park M, Shoemaker M, Stevens LA, Zolkiewska A.
Characterization of NAD:arginine ADP-ribosyltransferases.
Mol Cell Biochem 193(1-2): 109-13, 1999.
[Text Abstract on PubMed]
|
|
|
65
|
Moss J, Vaughan M.
Activation of toxin ADP-ribosyltransferases by eukaryotic ADP-ribosylation factors.
Mol Cell Biochem 193(1-2): 153-7, 1999.
[Text Abstract on PubMed]
|
|
|
66
|
Novoradovsky A, Brantly ML, Waclawiw MA, Chaudhary PP, Ihara H, Qi L, Eissa NT, Barnes PM, Gabriele KM, Ehrmantraut ME, Rogliani P, Moss J.
Endothelial nitric oxide synthase as a potential susceptibility gene in the pathogenesis of emphysema in alpha1-antitrypsin deficiency.
Am J Respir Cell Mol Biol 20(3): 441-7, 1999.
[Text Abstract on PubMed]
|
|
|
67
|
Okazaki IJ, Moss J.
Characterization of glycosylphosphatidylinositiol-anchored, secreted, and intracellular vertebrate mono-ADP-ribosyltransferases.
Annu Rev Nutr 19: 485-509, 1999.
[Text Abstract on PubMed]
|
|
|
68
|
Pacheco-Rodriguez G, Patton WA, Adamik R, Yoo HS, Lee FJ, Zhang GF, Moss J, Vaughan M.
Structural elements of ADP-ribosylation factor 1 required for functional interaction with cytohesin-1.
J Biol Chem 274(18): 12438-44, 1999.
[Text Abstract on PubMed]
|
|
|
69
|
Rivera-Nieves J, Thompson WC, Levine RL, Moss J.
Thiols mediate superoxide-dependent NADH modification of glyceraldehyde-3-phosphate dehydrogenase.
J Biol Chem 274(28): 19525-31, 1999.
[Text Abstract on PubMed]
|
|
|
70
|
Sata M, Moss J, Vaughan M.
Structural basis for the inhibitory effect of brefeldin A on guanine nucleotide-exchange proteins for ADP-ribosylation factors.
Proc Natl Acad Sci U S A 96(6): 2752-7, 1999.
[Text Abstract on PubMed]
|
|
|
71
|
Stevens LA, Moss J, Vaughan M, Pizza M, Rappuoli R.
Effects of site-directed mutagenesis of Escherichia coli heat-labile enterotoxin on ADP-ribosyltransferase activity and interaction with ADP-ribosylation factors.
Infect Immun 67(1): 259-65, 1999.
[Text Abstract on PubMed]
|
|
|
72
|
Togawa A, Morinaga N, Ogasawara M, Moss J, Vaughan M.
Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.
J Biol Chem 274(18): 12308-15, 1999.
[Text Abstract on PubMed]
|
|
|
73
|
Weng B, Thompson WC, Kim HJ, Levine RL, Moss J.
Modification of the ADP-ribosyltransferase and NAD glycohydrolase activities of a mammalian transferase (ADP-ribosyltransferase 5) by auto-ADP-ribosylation.
J Biol Chem 274(45): 31797-803, 1999.
[Text Abstract on PubMed]
|
|
|
74
|
Chu SC, Marks-Konczalik J, Wu HP, Banks TC, Moss J.
Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters.
Biochem Biophys Res Commun 248(3): 871-8, 1998.
[Text Abstract on PubMed]
|
|
|
75
|
Eissa NT, Yuan JW, Haggerty CM, Choo EK, Palmer CD, Moss J.
Cloning and characterization of human inducible nitric oxide synthase splice variants: a domain, encoded by exons 8 and 9, is critical for dimerization.
Proc Natl Acad Sci U S A 95(13): 7625-30, 1998.
[Text Abstract on PubMed]
|
|
|
76
|
Hong JX, Lee FJ, Patton WA, Lin CY, Moss J, Vaughan M.
Phospholipid- and GTP-dependent activation of cholera toxin and phospholipase D by human ADP-ribosylation factor-like protein 1 (HARL1).
J Biol Chem 273(25): 15872-6, 1998.
[Text Abstract on PubMed]
|
|
|
77
|
Lesma E, Moss J, Brewer HB, Bortell R, Greiner D, Mordes J, Rossini AA.
Characterization of high density lipoprotein-bound and soluble RT6 released following administration of anti-RT6.1 monoclonal antibody.
J Immunol 161(3): 1212-9, 1998.
[Text Abstract on PubMed]
|
|
|
78
|
Marks-Konczalik J, Chu SC, Moss J.
Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites.
J Biol Chem 273(35): 22201-8, 1998.
[Text Abstract on PubMed]
|
|
|
79
|
Moss J, Vaughan M.
Molecules in the ARF orbit.
J Biol Chem 273(34): 21431-4, 1998.
[Text Abstract on PubMed]
|
|
|
80
|
Okazaki IJ, Moss J.
Glycosylphosphatidylinositol-anchored and secretory isoforms of mono-ADP-ribosyltransferases.
J Biol Chem 273(37): 23617-20, 1998.
[Text Abstract on PubMed]
|
|
|
81
|
Pacheco-Rodriguez G, Meacci E, Vitale N, Moss J, Vaughan M.
Guanine nucleotide exchange on ADP-ribosylation factors catalyzed by cytohesin-1 and its Sec7 domain.
J Biol Chem 273(41): 26543-8, 1998.
[Text Abstract on PubMed]
|
|
|
82
|
Sata M, Donaldson JG, Moss J, Vaughan M.
Brefeldin A-inhibited guanine nucleotide-exchange activity of Sec7 domain from yeast Sec7 with yeast and mammalian ADP ribosylation factors.
Proc Natl Acad Sci U S A 95(8): 4204-8, 1998.
[Text Abstract on PubMed]
|
|
|
83
|
Sloand EM, Maciejewski JP, Dunn D, Moss J, Brewer B, Kirby M, Young NS.
Correction of the PNH defect by GPI-anchored protein transfer.
Blood 92(11): 4439-45, 1998.
[Text Abstract on PubMed]
|
|
|
84
|
Tsai SC, Adamik R, Hong JX, Moss J, Vaughan M, Kanoh H, Exton JH.
Effects of arfaptin 1 on guanine nucleotide-dependent activation of phospholipase D and cholera toxin by ADP-ribosylation factor.
J Biol Chem 273(33): 20697-701, 1998.
[Text Abstract on PubMed]
|
|
|
85
|
Usuki J, Horiba K, Chu SC, Moss J, Ferrans VJ.
Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: association of Bcl-2 expression with hormone receptor status.
Arch Pathol Lab Med 122(10): 895-902, 1998.
[Text Abstract on PubMed]
|
|
|
86
|
Vitale N, Horiba K, Ferrans VJ, Moss J, Vaughan M.
Localization of ADP-ribosylation factor domain protein 1 (ARD1) in lysosomes and Golgi apparatus.
Proc Natl Acad Sci U S A 95(15): 8613-8, 1998.
[Text Abstract on PubMed]
|
|
|
87
|
Vitale N, Moss J, Vaughan M.
Molecular characterization of the GTPase-activating domain of ADP-ribosylation factor domain protein 1 (ARD1).
J Biol Chem 273(5): 2553-60, 1998.
[Text Abstract on PubMed]
|
|
|
88
|
Zolkiewska A, Thompson WC, Moss J.
Interaction of integrin alpha 7 beta 1 in C2C12 myotubes and in solution with laminin.
Exp Cell Res 240(1): 86-94, 1998.
[Text Abstract on PubMed]
|
|
|
89
|
Hayashi T, Fleming MV, Stetler-Stevenson WG, Liotta LA, Moss J, Ferrans VJ, Travis WD.
Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).
Hum Pathol 28(9): 1071-8, 1997.
[Text Abstract on PubMed]
|
|
|
90
|
Kim HJ, Okazaki IJ, Takada T, Moss J.
An 18-kDa domain of a glycosylphosphatidylinositol-linked NAD:arginine ADP-ribosyltransferase possesses NAD glycohydrolase activity.
J Biol Chem 272(14): 8918-23, 1997.
[Text Abstract on PubMed]
|
|
|
91
|
Meacci E, Tsai SC, Adamik R, Moss J, Vaughan M.
Cytohesin-1, a cytosolic guanine nucleotide-exchange protein for ADP-ribosylation factor.
Proc Natl Acad Sci U S A 94(5): 1745-8, 1997.
[Text Abstract on PubMed]
|
|
|
92
|
Morinaga N, Moss J, Vaughan M.
Cloning and expression of a cDNA encoding a bovine brain brefeldin A-sensitive guanine nucleotide-exchange protein for ADP-ribosylation factor.
Proc Natl Acad Sci U S A 94(24): 12926-31, 1997.
[Text Abstract on PubMed]
|
|
|
93
|
Moss J, Stevens LA, Cavanaugh E, Okazaki IJ, Bortell R, Kanaitsuka T, Mordes JP, Greiner DL, Rossini AA.
Characterization of mouse Rt6.1 NAD:arginine ADP-ribosyltransferase.
J Biol Chem 272(7): 4342-6, 1997.
[Text Abstract on PubMed]
|
|
|
94
|
Moss J, Zolkiewska A, Okazaki I.
ADP-ribosylarginine hydrolases and ADP-ribosyltransferases. Partners in ADP-ribosylation cycles.
Adv Exp Med Biol 419: 25-33, 1997.
[Text Abstract on PubMed]
|
|
|
95
|
Okazaki IJ, Kim HJ, Moss J.
Molecular cloning and characterization of lymphocyte and muscle ADP-ribosyltransferases.
Adv Exp Med Biol 419: 129-36, 1997.
[Text Abstract on PubMed]
|
|
|
96
|
Shibutani T, Johnson TM, Yu ZX, Ferrans VJ, Moss J, Epstein SE.
Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells.
J Clin Invest 100(8): 2054-61, 1997.
[Text Abstract on PubMed]
|
|
|
97
|
Vaughan M, Moss J.
Activation of toxin ADP-ribosyltransferases by the family of ADP-ribosylation factors.
Adv Exp Med Biol 419: 315-20, 1997.
[Text Abstract on PubMed]
|
|
|
98
|
Vitale N, Moss J, Vaughan M.
Characterization of a GDP dissociation inhibitory region of ADP-ribosylation factor domain protein ARD1.
J Biol Chem 272(40): 25077-82, 1997.
[Text Abstract on PubMed]
|
|
|
99
|
Vitale N, Moss J, Vaughan M.
Interaction of the GTP-binding and GTPase-activating domains of ARD1 involves the effector region of the ADP-ribosylation factor domain.
J Biol Chem 272(7): 3897-904, 1997.
[Text Abstract on PubMed]
|
|
|
100
|
Zolkiewska A, Moss J.
The alpha 7 integrin as a target protein for cell surface mono-ADP-ribosylation in muscle cells.
Adv Exp Med Biol 419: 297-303, 1997.
[Text Abstract on PubMed]
|
|
|
101
|
Ding M, Vitale N, Tsai SC, Adamik R, Moss J, Vaughan M.
Characterization of a GTPase-activating protein that stimulates GTP hydrolysis by both ADP-ribosylation factor (ARF) and ARF-like proteins. Comparison to the ARD1 gap domain.
J Biol Chem 271(39): 24005-9, 1996.
[Text Abstract on PubMed]
|
|
|
102
|
Eissa NT, Strauss AJ, Haggerty CM, Choo EK, Chu SC, Moss J.
Alternative splicing of human inducible nitric-oxide synthase mRNA. tissue-specific regulation and induction by cytokines.
J Biol Chem 271(43): 27184-7, 1996.
[Text Abstract on PubMed]
|
|
|
103
|
Lee CM, Stevens LA, Hsu HC, Tsai SC, Lee YT, Moss J, Vaughan M.
Expression in human endothelial cells of ADP-ribosylation factors, 20-kDa guanine nucleotide-binding proteins involved in the initiation of vesicular transport.
J Mol Cell Cardiol 28(9): 1911-20, 1996.
[Text Abstract on PubMed]
|
|
|
104
|
Morinaga N, Tsai SC, Moss J, Vaughan M.
Isolation of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and ARF3 that contains a Sec7-like domain.
Proc Natl Acad Sci U S A 93(23): 12856-60, 1996.
[Text Abstract on PubMed]
|
|
|
105
|
Okazaki IJ, Kim HJ, McElvaney NG, Lesma E, Moss J.
Molecular characterization of a glycosylphosphatidylinositol-linked ADP-ribosyltransferase from lymphocytes.
Blood 88(3): 915-21, 1996.
[Text Abstract on PubMed]
|
|
|
106
|
Okazaki IJ, Kim HJ, Moss J.
Cloning and characterization of a novel membrane-associated lymphocyte NAD:arginine ADP-ribosyltransferase.
J Biol Chem 271(36): 22052-7, 1996.
[Text Abstract on PubMed]
|
|
|
107
|
Okazaki IJ, Moss J.
Mono-ADP-ribosylation: a reversible posttranslational modification of proteins.
Adv Pharmacol 35: 247-80, 1996.
[Text Abstract on PubMed]
|
|
|
108
|
Okazaki IJ, Moss J.
Structure and function of eukaryotic mono-ADP-ribosyltransferases.
Rev Physiol Biochem Pharmacol 129: 51-104, 1996.
[Text Abstract on PubMed]
|
|
|
109
|
Price SR, Nightingale MS, Tsuchiya M, Moss J, Vaughan M.
Interspecies relationships among ADP-ribosylation factors (ARFs): evidence of evolutionary pressure to maintain individual identities.
Mol Cell Biochem 159(1): 15-23, 1996.
[Text Abstract on PubMed]
|
|
|
110
|
Tsai SC, Adamik R, Moss J, Vaughan M.
Purification and characterization of a guanine nucleotide-exchange protein for ADP-ribosylation factor from spleen cytosol.
Proc Natl Acad Sci U S A 93(1): 305-9, 1996.
[Text Abstract on PubMed]
|
|
|
111
|
Vitale N, Moss J, Vaughan M.
ARD1, a 64-kDa bifunctional protein containing an 18-kDa GTP-binding ADP-ribosylation factor domain and a 46-kDa GTPase-activating domain.
Proc Natl Acad Sci U S A 93(5): 1941-4, 1996.
[Text Abstract on PubMed]
|
|
|
112
|
Hong JX, Zhang X, Moss J, Vaughan M.
Isolation of an amino-terminal deleted recombinant ADP-ribosylation factor 1 in an activated nucleotide-free state.
Proc Natl Acad Sci U S A 92(7): 3056-9, 1995.
[Text Abstract on PubMed]
|
|
|
113
|
Justice JM, Bliziotes MM, Stevens LA, Moss J, Vaughan M.
Involvement of N-myristoylation in monoclonal antibody recognition sites on chimeric G protein alpha subunits.
J Biol Chem 270(12): 6436-9, 1995.
[Text Abstract on PubMed]
|
|
|
114
|
Justice JM, Murtagh JJ, Moss J, Vaughan M.
Hydrophobicity and subunit interactions of rod outer segment proteins investigated using Triton X-114 phase partitioning.
J Biol Chem 270(30): 17970-6, 1995.
[Text Abstract on PubMed]
|
|
|
115
|
Moss J, Vaughan M.
Structure and function of ARF proteins: activators of cholera toxin and critical components of intracellular vesicular transport processes.
J Biol Chem 270(21): 12327-30, 1995.
[Text Abstract on PubMed]
|
|
|
116
|
Okazaki IJ, Zolkiewska A, Takada T, Moss J.
Characterization of mammalian ADP-ribosylation cycles.
Biochimie 77(5): 319-25, 1995.
[Text Abstract on PubMed]
|
|
|
117
|
Takada T, Iida K, Moss J.
Conservation of a common motif in enzymes catalyzing ADP-ribose transfer. Identification of domains in mammalian transferases.
J Biol Chem 270(2): 541-4, 1995.
[Text Abstract on PubMed]
|
|
|
118
|
Zhang GF, Patton WA, Lee FJ, Liyanage M, Han JS, Rhee SG, Moss J, Vaughan M.
Different ARF domains are required for the activation of cholera toxin and phospholipase D.
J Biol Chem 270(1): 21-4, 1995.
[Text Abstract on PubMed]
|
|
|
119
|
Zolkiewska A, Moss J.
Processing of ADP-ribosylated integrin alpha 7 in skeletal muscle myotubes.
J Biol Chem 270(16): 9227-33, 1995.
[Text Abstract on PubMed]
|
|
|
120
|
Hong JX, Haun RS, Tsai SC, Moss J, Vaughan M.
Effect of ADP-ribosylation factor amino-terminal deletions on its GTP-dependent stimulation of cholera toxin activity.
J Biol Chem 269(13): 9743-5, 1994.
[Text Abstract on PubMed]
|
|
|
121
|
Lee FJ, Stevens LA, Hall LM, Murtagh JJ, Kao YL, Moss J, Vaughan M.
Characterization of class II and class III ADP-ribosylation factor genes and proteins in Drosophila melanogaster.
J Biol Chem 269(34): 21555-60, 1994.
[Text Abstract on PubMed]
|
|
|
122
|
Lee FJ, Stevens LA, Kao YL, Moss J, Vaughan M.
Characterization of a glucose-repressible ADP-ribosylation factor 3 (ARF3) from Saccharomyces cerevisiae.
J Biol Chem 269(33): 20931-7, 1994.
[Text Abstract on PubMed]
|
|
|
123
|
Massenburg D, Han JS, Liyanage M, Patton WA, Rhee SG, Moss J, Vaughan M.
Activation of rat brain phospholipase D by ADP-ribosylation factors 1,5, and 6: separation of ADP-ribosylation factor-dependent and oleate-dependent enzymes.
Proc Natl Acad Sci U S A 91(24): 11718-22, 1994.
[Text Abstract on PubMed]
|
|
|
124
|
McDonald LJ, Moss J.
Enzymatic and nonenzymatic ADP-ribosylation of cysteine.
Mol Cell Biochem 138(1-2): 221-6, 1994.
[Text Abstract on PubMed]
|
|
|
125
|
McDonald LJ, Moss J.
Nitric oxide and NAD-dependent protein modification.
Mol Cell Biochem 138(1-2): 201-6, 1994.
[Text Abstract on PubMed]
|
|
|
126
|
Moss J, Haun RS, Tsai SC, Welsh CF, Lee FJ, Price SR, Vaughan M.
Activation of cholera toxin by ADP-ribosylation factors: 20-kDa guanine nucleotide-binding proteins.
Methods Enzymol 237: 44-63, 1994.
[Text Abstract on PubMed]
|
|
|
127
|
Moss J, Tsai SC, Vaughan M.
Activation of cholera toxin by ADP-ribosylation factors.
Methods Enzymol 235: 640-7, 1994.
[Text Abstract on PubMed]
|
|
|
128
|
Murayama T, Hewlett EL, Maloney NJ, Justice JM, Moss J.
Effect of temperature and host factors on the activities of pertussis toxin and Bordetella adenylate cyclase.
Biochemistry 33(51): 15293-7, 1994.
[Text Abstract on PubMed]
|
|
|
129
|
Murtagh JJ, Moss J, Vaughan M.
Alternative splicing of the guanine nucleotide-binding regulatory protein Go alpha generates four distinct mRNAs.
Nucleic Acids Res 22(5): 842-9, 1994.
[Text Abstract on PubMed]
|
|
|
130
|
Okazaki IJ, Moss J.
Common structure of the catalytic sites of mammalian and bacterial toxin ADP-ribosyltransferases.
Mol Cell Biochem 138(1-2): 177-81, 1994.
[Text Abstract on PubMed]
|
|
|
131
|
Okazaki IJ, Zolkiewska A, Nightingale MS, Moss J.
Immunological and structural conservation of mammalian skeletal muscle glycosylphosphatidylinositol-linked ADP-ribosyltransferases.
Biochemistry 33(43): 12828-36, 1994.
[Text Abstract on PubMed]
|
|
|
132
|
Takada T, Iida K, Moss J.
Expression of NAD glycohydrolase activity by rat mammary adenocarcinoma cells transformed with rat T cell alloantigen RT6.2.
J Biol Chem 269(13): 9420-3, 1994.
[Text Abstract on PubMed]
|
|
|
133
|
Takada T, Okazaki IJ, Moss J.
ADP-ribosylarginine hydrolases.
Mol Cell Biochem 138(1-2): 119-22, 1994.
[Text Abstract on PubMed]
|
|
|
134
|
Tsai SC, Adamik R, Moss J, Vaughan M.
Identification of a brefeldin A-insensitive guanine nucleotide-exchange protein for ADP-ribosylation factor in bovine brain.
Proc Natl Acad Sci U S A 91(8): 3063-6, 1994.
[Text Abstract on PubMed]
|
|
|
135
|
Welsh CF, Moss J, Vaughan M.
ADP-ribosylation factors: a family of approximately 20-kDa guanine nucleotide-binding proteins that activate cholera toxin.
Mol Cell Biochem 138(1-2): 157-66, 1994.
[Text Abstract on PubMed]
|
|
|
136
|
Welsh CF, Moss J, Vaughan M.
Isolation of recombinant ADP-ribosylation factor 6, an approximately 20-kDa guanine nucleotide-binding protein, in an activated GTP-bound state.
J Biol Chem 269(22): 15583-7, 1994.
[Text Abstract on PubMed]
|
|
|
137
|
Zolkiewska A, Okazaki IJ, Moss J.
Vertebrate mono-ADP-ribosyltransferases.
Mol Cell Biochem 138(1-2): 107-12, 1994.
[Text Abstract on PubMed]
|
|
|
138
|
Haun RS, Moss J, Vaughan M.
Characterization of the human ADP-ribosylation factor 3 promoter. Transcriptional regulation of a TATA-less promoter.
J Biol Chem 268(12): 8793-800, 1993.
[Text Abstract on PubMed]
|
|
|
139
|
Haun RS, Tsai SC, Adamik R, Moss J, Vaughan M.
Effect of myristoylation on GTP-dependent binding of ADP-ribosylation factor to Golgi.
J Biol Chem 268(10): 7064-8, 1993.
[Text Abstract on PubMed]
|
|
|
140
|
Kunz BC, Muczynski KA, Welsh CF, Stanley SJ, Tsai SC, Adamik R, Chang PP, Moss J, Vaughan M.
Characterization of recombinant and endogenous ADP-ribosylation factors synthesized in Sf9 insect cells.
Biochemistry 32(26): 6643-8, 1993.
[Text Abstract on PubMed]
|
|
|
141
|
Lee FJ, Moss J.
An RNA-binding protein gene (RBP1) of Saccharomyces cerevisiae encodes a putative glucose-repressible protein containing two RNA recognition motifs.
J Biol Chem 268(20): 15080-7, 1993.
[Text Abstract on PubMed]
|
|
|
142
|
McDonald LJ, Moss J.
Nitric oxide-independent, thiol-associated ADP-ribosylation inactivates aldehyde dehydrogenase.
J Biol Chem 268(24): 17878-82, 1993.
[Text Abstract on PubMed]
|
|
|
143
|
McDonald LJ, Moss J.
Pleiotropic effects of nitric oxide on ADP-ribosylation, covalent binding of NAD, and catalytic activity of glyceraldehyde-3-phosphate and aldehyde dehydrogenases.
Trans Assoc Am Physicians 106: 155-61, 1993.
[Text Abstract on PubMed]
|
|
|
144
|
McDonald LJ, Moss J.
Stimulation by nitric oxide of an NAD linkage to glyceraldehyde-3-phosphate dehydrogenase.
Proc Natl Acad Sci U S A 90(13): 6238-41, 1993.
[Text Abstract on PubMed]
|
|
|
145
|
Mishima K, Tsuchiya M, Nightingale MS, Moss J, Vaughan M.
ARD 1, a 64-kDa guanine nucleotide-binding protein with a carboxyl-terminal ADP-ribosylation factor domain.
J Biol Chem 268(12): 8801-7, 1993.
[Text Abstract on PubMed]
|
|
|
146
|
Moss J, Stanley SJ, Vaughan M, Tsuji T.
Interaction of ADP-ribosylation factor with Escherichia coli enterotoxin that contains an inactivating lysine 112 substitution.
J Biol Chem 268(9): 6383-7, 1993.
[Text Abstract on PubMed]
|
|
|
147
|
Moss J, Vaughan M.
ADP-ribosylation factors, 20,000 M(r) guanine nucleotide-binding protein activators of cholera toxin and components of intracellular vesicular transport systems.
Cell Signal 5(4): 367-79, 1993.
[Text Abstract on PubMed]
|
|
|
148
|
Moss J, Vaughan M.
ADP-ribosylation factors: protein activators of cholera toxin.
Prog Nucleic Acid Res Mol Biol 45: 47-65, 1993.
[Text Abstract on PubMed]
|
|
|
149
|
Murayama T, Tsai SC, Adamik R, Moss J, Vaughan M.
Effects of temperature on ADP-ribosylation factor stimulation of cholera toxin activity.
Biochemistry 32(2): 561-6, 1993.
[Text Abstract on PubMed]
|
|
|
150
|
Murtagh JJ, Lee FJ, Deak P, Hall LM, Monaco L, Lee CM, Stevens LA, Moss J, Vaughan M.
Molecular characterization of a conserved, guanine nucleotide-dependent ADP-ribosylation factor in Drosophila melanogaster.
Biochemistry 32(23): 6011-8, 1993.
[Text Abstract on PubMed]
|
|
|
151
|
Serventi IM, Cavanaugh E, Moss J, Vaughan M.
Characterization of the gene for ADP-ribosylation factor (ARF) 2, a developmentally regulated, selectively expressed member of the ARF family of approximately 20-kDa guanine nucleotide-binding proteins.
J Biol Chem 268(7): 4863-72, 1993.
[Text Abstract on PubMed]
|
|
|
152
|
Takada T, Iida K, Moss J.
Cloning and site-directed mutagenesis of human ADP-ribosylarginine hydrolase.
J Biol Chem 268(24): 17837-43, 1993.
[Text Abstract on PubMed]
|
|
|
153
|
Tsai SC, Adamik R, Haun RS, Moss J, Vaughan M.
Effects of brefeldin A and accessory proteins on association of ADP-ribosylation factors 1, 3, and 5 with Golgi.
J Biol Chem 268(15): 10820-5, 1993.
[Text Abstract on PubMed]
|
|
|
154
|
Zolkiewska A, Moss J.
Integrin alpha 7 as substrate for a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase on the surface of skeletal muscle cells.
J Biol Chem 268(34): 25273-6, 1993.
[Text Abstract on PubMed]
|
|
|
155
|
Avigan J, Murtagh JJ, Stevens LA, Angus CW, Moss J, Vaughan M.
Pertussis toxin-catalyzed ADP-ribosylation of G(o) alpha with mutations at the carboxyl terminus.
Biochemistry 31(33): 7736-40, 1992.
[Text Abstract on PubMed]
|
|
|
156
|
Francis ML, Ryan J, Jobling MG, Holmes RK, Moss J, Mond JJ.
Cyclic AMP-independent effects of cholera toxin on B cell activation. II. Binding of ganglioside GM1 induces B cell activation.
J Immunol 148(7): 1999-2005, 1992.
[Text Abstract on PubMed]
|
|
|
157
|
Haun RS, Moss J.
Ligation-independent cloning of glutathione S-transferase fusion genes for expression in Escherichia coli.
Gene 112(1): 37-43, 1992.
[Text Abstract on PubMed]
|
|
|
158
|
Haun RS, Serventi IM, Moss J.
Rapid, reliable ligation-independent cloning of PCR products using modified plasmid vectors.
Biotechniques 13(4): 515-8, 1992.
[Text Abstract on PubMed]
|
|
|
159
|
Lee CM, Haun RS, Tsai SC, Moss J, Vaughan M.
Characterization of the human gene encoding ADP-ribosylation factor 1, a guanine nucleotide-binding activator of cholera toxin.
J Biol Chem 267(13): 9028-34, 1992.
[Text Abstract on PubMed]
|
|
|
160
|
Lee FJ, Moss J, Lin LW.
A simplified procedure for hybridization of RNA blots.
Biotechniques 13(6): 844-6, 1992.
[Text Abstract on PubMed]
|
|
|
161
|
Lee FJ, Moss J, Vaughan M.
Human and Giardia ADP-ribosylation factors (ARFs) complement ARF function in Saccharomyces cerevisiae.
J Biol Chem 267(34): 24441-5, 1992.
[Text Abstract on PubMed]
|
|
|
162
|
McDonald LJ, Wainschel LA, Oppenheimer NJ, Moss J.
Amino acid-specific ADP-ribosylation: structural characterization and chemical differentiation of ADP-ribose-cysteine adducts formed nonenzymatically and in a pertussis toxin-catalyzed reaction.
Biochemistry 31(47): 11881-7, 1992.
[Text Abstract on PubMed]
|
|
|
163
|
Mishima K, Price SR, Nightingale MS, Kousvelari E, Moss J, Vaughan M.
Regulation of ADP-ribosylation factor (ARF) expression. Cross-species conservation of the developmental and tissue-specific alternative polyadenylation of ARF 4 mRNA.
J Biol Chem 267(33): 24109-16, 1992.
[Text Abstract on PubMed]
|
|
|
164
|
Moss J, Stanley SJ, Nightingale MS, Murtagh JJ, Monaco L, Mishima K, Chen HC, Williamson KC, Tsai SC.
Molecular and immunological characterization of ADP-ribosylarginine hydrolases.
J Biol Chem 267(15): 10481-8, 1992.
[Text Abstract on PubMed]
|
|
|
165
|
Moss J, Vaughan M.
Activation of cholera toxin by ADP-ribosylation factors, 20-kDa guanine nucleotide-binding proteins.
Curr Top Cell Regul 32: 49-72, 1992.
[Text Abstract on PubMed]
|
|
|
166
|
Murtagh JJ, Mowatt MR, Lee CM, Lee FJ, Mishima K, Nash TE, Moss J, Vaughan M.
Guanine nucleotide-binding proteins in the intestinal parasite Giardia lamblia. Isolation of a gene encoding an approximately 20-kDa ADP-ribosylation factor.
J Biol Chem 267(14): 9654-62, 1992.
[Text Abstract on PubMed]
|
|
|
167
|
Price SR, Nightingale MS, Bobak DA, Tsuchiya M, Moss J, Vaughan M.
Conservation of a 23-kDa human transplantation antigen in mammalian species.
Genomics 14(4): 959-64, 1992.
[Text Abstract on PubMed]
|
|
|
168
|
Price SR, Welsh CF, Haun RS, Stanley SJ, Moss J, Vaughan M.
Effects of phospholipid and GTP on recombinant ADP-ribosylation factors (ARFs). Molecular basis for differences in requirements for activity of mammalian ARFs.
J Biol Chem 267(25): 17766-72, 1992.
[Text Abstract on PubMed]
|
|
|
169
|
Serventi IM, Moss J, Vaughan M.
Enhancement of cholera toxin-catalyzed ADP-ribosylation by guanine nucleotide-binding proteins.
Curr Top Microbiol Immunol 175: 43-67, 1992.
[Text Abstract on PubMed]
|
|
|
170
|
Tsai SC, Adamik R, Haun RS, Moss J, Vaughan M.
Differential interaction of ADP-ribosylation factors 1, 3, and 5 with rat brain Golgi membranes.
Proc Natl Acad Sci U S A 89(19): 9272-6, 1992.
[Text Abstract on PubMed]
|
|
|
171
|
Walker MW, Bobak DA, Tsai SC, Moss J, Vaughan M.
GTP but not GDP analogues promote association of ADP-ribosylation factors, 20-kDa protein activators of cholera toxin, with phospholipids and PC-12 cell membranes.
J Biol Chem 267(5): 3230-5, 1992.
[Text Abstract on PubMed]
|
|
|
172
|
Welsh CF, Moss J, Vaughan M.
ADP-ribosylation factor, a guanine nucleotide-binding protein activator of cholera toxin, is isolated in an activated state when expressed as a fusion protein in Escherichia coli.
Trans Assoc Am Physicians 105: 172-6, 1992.
[Text Abstract on PubMed]
|
|
|
173
|
Zolkiewska A, Nightingale MS, Moss J.
Molecular characterization of NAD:arginine ADP-ribosyltransferase from rabbit skeletal muscle.
Proc Natl Acad Sci U S A 89(23): 11352-6, 1992.
[Text Abstract on PubMed]
|
|
|
174
|
Chu CS, Trapnell BC, Murtagh JJ, Moss J, Dalemans W, Jallat S, Mercenier A, Pavirani A, Lecocq JP, Cutting GR.
Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium.
EMBO J 10(6): 1355-63, 1991.
[Text Abstract on PubMed]
|
|
|
175
|
Hide M, Ali H, Price SR, Moss J, Beaven MA.
GTP-binding protein G alpha Z: its down-regulation by dexamethasone and its credentials as a mediator of antigen-induced responses in RBL-2H3 cells.
Mol Pharmacol 40(4): 473-9, 1991.
[Text Abstract on PubMed]
|
|
|
176
|
Lee CM, Chang PP, Tsai SC, Adamik R, Price SR, Kunz BC, Moss J, Twiddy EM, Holmes RK.
Activation of Escherichia coli heat-labile enterotoxins by native and recombinant adenosine diphosphate-ribosylation factors, 20-kD guanine nucleotide-binding proteins.
J Clin Invest 87(5): 1780-6, 1991.
[Text Abstract on PubMed]
|
|
|
177
|
Lee FJ, Moss J.
Cloning of a Saccharomyces cerevisiae gene encoding a protein homologous to allantoicase of Neurospora crassa.
Yeast 7(9): 993-5, 1991.
[Text Abstract on PubMed]
|
|
|
178
|
Moss J, Vaughan M.
Activation of cholera toxin and Escherichia coli heat-labile enterotoxins by ADP-ribosylation factors, a family of 20 kDa guanine nucleotide-binding proteins.
Mol Microbiol 5(11): 2621-7, 1991.
[Text Abstract on PubMed]
|
|
|
179
|
Murtagh JJ, Eddy R, Shows TB, Moss J, Vaughan M.
Different forms of Go alpha mRNA arise by alternative splicing of transcripts from a single gene on human chromosome 16.
Mol Cell Biol 11(2): 1146-55, 1991.
[Text Abstract on PubMed]
|
|
|
180
|
Tsai SC, Adamik R, Moss J, Vaughan M.
Guanine nucleotide dependent formation of a complex between choleragen (cholera toxin) a subunit and bovine brain ADP-ribosylation factor.
Biochemistry 30(15): 3697-703, 1991.
[Text Abstract on PubMed]
|
|
|
181
|
Tsai SC, Adamik R, Tsuchiya M, Chang PP, Moss J, Vaughan M.
Differential expression during development of ADP-ribosylation factors, 20-kDa guanine nucleotide-binding protein activators of cholera toxin.
J Biol Chem 266(13): 8213-9, 1991.
[Text Abstract on PubMed]
|
|
|
182
|
Tsai SC, Haun RS, Tsuchiya M, Moss J, Vaughan M.
Isolation and characterization of the human gene for ADP-ribosylation factor 3, a 20-kDa guanine nucleotide-binding protein activator of cholera toxin.
J Biol Chem 266(34): 23053-9, 1991.
[Text Abstract on PubMed]
|
|
|
183
|
Tsuchiya M, Price SR, Tsai SC, Moss J, Vaughan M.
Molecular identification of ADP-ribosylation factor mRNAs and their expression in mammalian cells.
J Biol Chem 266(5): 2772-7, 1991.
[Text Abstract on PubMed]
|
|
|
184
|
Bobak DA, Bliziotes MM, Noda M, Tsai SC, Adamik R, Moss J.
Mechanism of activation of cholera toxin by ADP-ribosylation factor (ARF): both low- and high-affinity interactions of ARF with guanine nucleotides promote toxin activation.
Biochemistry 29(4): 855-61, 1990.
[Text Abstract on PubMed]
|
|
|
185
|
Francis ML, Moss J, Fitz TA, Mond JJ.
cAMP-independent effects of cholera toxin on B cell activation. I. A possible role for cell surface ganglioside GM1 in B cell activation.
J Immunol 145(10): 3162-9, 1990.
[Text Abstract on PubMed]
|
|
|
186
|
Halpern JL, Moss J.
Immunological characterization of guanine nucleotide-binding proteins: effects of a monoclonal antibody against the gamma subunit of transducin on guanine nucleotide-binding protein-receptor interactions.
Mol Pharmacol 37(6): 797-800, 1990.
[Text Abstract on PubMed]
|
|
|
187
|
Monaco L, Murtagh JJ, Newman KB, Tsai SC, Moss J, Vaughan M.
Selective amplification of an mRNA and related pseudogene for a human ADP-ribosylation factor, a guanine nucleotide-dependent protein activator of cholera toxin.
Proc Natl Acad Sci U S A 87(6): 2206-10, 1990.
[Text Abstract on PubMed]
|
|
|
188
|
Moss J, Stanley SJ, Levine RL.
Inactivation of bacterial glutamine synthetase by ADP-ribosylation.
J Biol Chem 265(34): 21056-60, 1990.
[Text Abstract on PubMed]
|
|
|
189
|
Moss J, Tsuchiya M, Tsai SC, Adamik R, Bobak DA, Price SR, Nightingale MS, Vaughan M.
Structural and functional characterization of ADP-ribosylation factors, 20 kDa guanine nucleotide-binding proteins that activate cholera toxin.
Adv Second Messenger Phosphoprotein Res 24: 83-8, 1990.
[Text Abstract on PubMed]
|
|
|
190
|
Noda M, Tsai SC, Adamik R, Moss J, Vaughan M.
Mechanism of cholera toxin activation by a guanine nucleotide-dependent 19 kDa protein.
Biochim Biophys Acta 1034(2): 195-9, 1990.
[Text Abstract on PubMed]
|
|
|
191
|
Williamson KC, Smith LA, Moss J, Vaughan M.
Guanine nucleotide-dependent ADP-ribosylation of soluble rho catalyzed by Clostridium botulinum C3 ADP-ribosyltransferase. Isolation and characterization of a newly recognized form of rhoA.
J Biol Chem 265(34): 20807-12, 1990.
[Text Abstract on PubMed]
|
|
|
192
|
Williamson KC, Smith LA, Moss J, Vaughan M.
Role of guanine nucleotide-binding proteins in Clostridium botulinum pathology: purification of substrates for Clostridium botulinum C3 ADP-ribosyltransferase with different requirements for GTP and phospholipids.
Trans Assoc Am Physicians 103: 281-8, 1990.
[Text Abstract on PubMed]
|
|
|
193
|
Bahnson TD, Tsai SC, Adamik R, Moss J, Vaughan M.
Microinjection of a 19-kDa guanine nucleotide-binding protein inhibits maturation of Xenopus oocytes.
J Biol Chem 264(25): 14824-8, 1989.
[Text Abstract on PubMed]
|
|
|
194
|
Bobak DA, Nightingale MS, Murtagh JJ, Price SR, Moss J, Vaughan M.
Molecular cloning, characterization, and expression of human ADP-ribosylation factors: two guanine nucleotide-dependent activators of cholera toxin.
Proc Natl Acad Sci U S A 86(16): 6101-5, 1989.
[Text Abstract on PubMed]
|
|
|
195
|
Noda M, Kunz BC, Tsai SC, Adamik R, Murtagh JJ, Chen HC, Halpern JL, Moss J.
Isolation and immunological properties of adenosine kinase.
Prep Biochem 19(4): 351-61, 1989.
[Text Abstract on PubMed]
|
|
|
196
|
Noda M, Tsai SC, Adamik R, Bobak DA, Moss J, Vaughan M.
Activation of immobilized, biotinylated choleragen AI protein by a 19-kilodalton guanine nucleotide-binding protein.
Biochemistry 28(19): 7936-40, 1989.
[Text Abstract on PubMed]
|
|
|
197
|
Price SR, Tsai SC, Adamik R, Angus CW, Serventi IM, Tsuchiya M, Moss J, Vaughan M.
Expression of Go alpha mRNA and protein in bovine tissues.
Biochemistry 28(9): 3803-7, 1989.
[Text Abstract on PubMed]
|
|
|
198
|
Tsai SC, Adamik R, Manganiello VC, Moss J.
Effects of nitroprusside and nitroglycerin on cGMP content and PGI2 formation in aorta and vena cava.
Biochem Pharmacol 38(1): 61-5, 1989.
[Text Abstract on PubMed]
|
|
|
199
|
Tsuchiya M, Price SR, Nightingale MS, Moss J, Vaughan M.
Tissue and species distribution of mRNA encoding two ADP-ribosylation factors, 20-kDa guanine nucleotide binding proteins.
Biochemistry 28(25): 9668-73, 1989.
[Text Abstract on PubMed]
|
|
|
200
|
Vaughan M, Tsai SC, Noda M, Adamik R, Moss J.
Participation of a guanine nucleotide-binding protein cascade in cholera toxin activation of adenylate cyclase.
J Mol Cell Cardiol 21 Suppl 1: 97-102, 1989.
[Text Abstract on PubMed]
|
|
|
201
|
Kanaho Y, Chang PP, Moss J, Vaughan M.
Mechanism of inhibition of transducin guanosine triphosphatase activity by vanadate.
J Biol Chem 263(33): 17584-9, 1988.
[Text Abstract on PubMed]
|
|
|
202
|
Kovacs JA, Halpern JL, Swan JC, Moss J, Parrillo JE, Masur H.
Identification of antigens and antibodies specific for Pneumocystis carinii.
J Immunol 140(6): 2023-31, 1988.
[Text Abstract on PubMed]
|
|
|
203
|
Lee MA, West RE, Moss J.
Atrial natriuretic factor reduces cyclic adenosine monophosphate content of human fibroblasts by enhancing phosphodiesterase activity.
J Clin Invest 82(2): 388-93, 1988.
[Text Abstract on PubMed]
|
|
|
204
|
Moss J, Hom BE, Hewlett EL, Tsai SC, Adamik R, Halpern JL, Price SR, Manganiello VC.
Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
Mol Pharmacol 34(3): 279-85, 1988.
[Text Abstract on PubMed]
|
|
|
205
|
Moss J, Tsai SC, Adamik R, Chen HC, Stanley SJ.
Purification and characterization of ADP-ribosylarginine hydrolase from turkey erythrocytes.
Biochemistry 27(15): 5819-23, 1988.
[Text Abstract on PubMed]
|
|
|
206
|
Moss J, Vaughan M.
ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins.
Adv Enzymol Relat Areas Mol Biol 61: 303-79, 1988.
[Text Abstract on PubMed]
|
|
|
207
|
Murtagh JJ, Price SR, Van Meurs KP, Angus CW, Moss J, Vaughan M.
Signal transduction by guanine nucleotide-binding proteins: possible molecular basis for multiple forms of Go alpha mRNA.
Trans Assoc Am Physicians 101: 235-41, 1988.
[Text Abstract on PubMed]
|
|
|
208
|
Price SR, Nightingale M, Tsai SC, Williamson KC, Adamik R, Chen HC, Moss J, Vaughan M.
Guanine nucleotide-binding proteins that enhance choleragen ADP-ribosyltransferase activity: nucleotide and deduced amino acid sequence of an ADP-ribosylation factor cDNA.
Proc Natl Acad Sci U S A 85(15): 5488-91, 1988.
[Text Abstract on PubMed]
|
|
|
209
|
Tsai SC, Adamik R, Moss J, Aktories K.
Separation of the 24 kDa substrate for botulinum C3 ADP-ribosyltransferase and the cholera toxin ADP-ribosylation factor.
Biochem Biophys Res Commun 152(3): 957-61, 1988.
[Text Abstract on PubMed]
|
|
|
210
|
Tsai SC, Noda M, Adamik R, Chang PP, Chen HC, Moss J, Vaughan M.
Stimulation of choleragen enzymatic activities by GTP and two soluble proteins purified from bovine brain.
J Biol Chem 263(4): 1768-72, 1988.
[Text Abstract on PubMed]
|
|
|
211
|
Tsai SC, Adamik R, Kanaho Y, Halpern JL, Moss J.
Immunological and biochemical differentiation of guanyl nucleotide binding proteins: interaction of Go alpha with rhodopsin, anti-Go alpha polyclonal antibodies, and a monoclonal antibody against transducin alpha subunit and Gi alpha.
Biochemistry 26(15): 4728-33, 1987.
[Text Abstract on PubMed]
|
|
|
212
|
Watkins PA, Kanaho Y, Moss J.
Inhibition of the GTPase activity of transducin by an NAD+:arginine ADP-ribosyltransferase from turkey erythrocytes.
Biochem J 248(3): 749-54, 1987.
[Text Abstract on PubMed]
|
|
|